Analysis of the long‑term beneficial effects of menopausal hormone therapy on sleep quality and menopausal symptoms

Li,Caixia; Wang,Li; Sun,Xiaohua; Yang,Xiaomei

doi:10.3892/etm.2019.8058

Analysis of the long‑term beneficial effects of menopausal hormone therapy on sleep quality and menopausal symptoms

Authors:
- Caixia Li
- Li Wang
- Xiaohua Sun
- Xiaomei Yang
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, Maternity and Child Health Care of Zaozhuang, Zaozhuang, Shandong 277100, P.R. China
Published online on: September 27, 2019 https://doi.org/10.3892/etm.2019.8058
Pages: 3905-3912
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

A large number of menopausal women report sleep disturbances along with psychological, somatic and urogenital menopausal symptoms. The aim of this study was to evaluate the efficacy of menopausal hormonal therapy (MHT) in improving subjective sleep quality and the severity of menopausal symptoms. An institutional ethics committee approved this retrospective chart review of 342 women treated with MHT for menopausal symptoms. Standard 28‑day MHT consisted of the oral administration of 2 mg estradiol daily for 14 days, followed by 2 mg estradiol and 10 mg dydrogesterone daily for the remaining 14 days. A subgroup of 14 participants with a family history of cancer and mammography scores of 3 and above, received only tibolone 2.5 mg daily. Perceived sleep quality was measured with the Pittsburgh Sleep Quality Index (PSQI), while the assessment of menopausal symptoms was performed using the Kupperman Menopause Index (KMI) and menopause rating scale (MRS). Of the 342 patients, 79 were followed‑up for 3 years. Compared to the baseline scores, the mean decrease in PSQI scores was 1.53±0.29 points (P<0.0001) at 1 month, 2.21±0.187 points (P<0.0001) at 2 months and 2.26±0.6 points (P<0.0001) after 3 years of MHT. The KMI scores also decreased by a mean of 6.37±1.59 points (P<0.0001) at 1 month and by 8.73±1.92 points after 3 years (P<0.0001). The MRS scores decreased by a mean of 3.56±1.05 points (P<0.0001) at 1 month and by 4.28±2.01 points (P<0.0001) after 3 years, as compared to the baseline scores. Patients receiving tibolone MHT did not report any improvement in sleep quality (P=0.956). On the whole, the findings of this study indicate that conventional MHT has a rapid and prolonged beneficial effect on self‑reported sleep quality and menopausal symptoms in women. However, further clinical studies are warranted to compare the effects of different MHT regimens.

View Figures

View References

1	Jehan S, Masters-Isarilov A, Salifu I, Zizi F, Jean-Louis G, Pandi-Perumal SR, Gupta R, Brzezinski A and McFarlane SI: Sleep Disorders in Postmenopausal Women. J Sleep Disord Ther. 4:42015.
2	Al-Safi ZA and Santoro N: Menopausal hormone therapy and menopausal symptoms. Fertil Steril. 101:905–915. 2014. View Article : Google Scholar : PubMed/NCBI
3	Potthoff P, Heinemann LA, Schneider HP, Rosemeier HP and Hauser GA: The Menopause Rating Scale (MRS II): Methodological standardization in the German population. Zentralbl Gynakol. 122:280–286. 2000.(In German). PubMed/NCBI
4	Schneider HP, Heinemann LA, Rosemeier HP, Potthoff P and Behre HM: The Menopause Rating Scale (MRS): Reliability of scores of menopausal complaints. Climacteric. 3:59–64. 2000. View Article : Google Scholar : PubMed/NCBI
5	Kupperman HS, Blatt MH, Wiesbader H and Filler W: Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices. J Clin Endocrinol Metab. 13:688–703. 1953. View Article : Google Scholar : PubMed/NCBI
6	Tao M, Shao H, Li C and Teng Y: Correlation between the modified Kupperman Index and the Menopause Rating Scale in Chinese women. Patient Prefer Adherence. 7:223–229. 2013.PubMed/NCBI
7	Mitchell ES and Woods NF: Symptom experiences of midlife women: Observations from the Seattle Midlife Women's Health Study. Maturitas. 25:1–10. 1996. View Article : Google Scholar : PubMed/NCBI
8	Lai JN, Chen HJ, Chen CM, Chen PC and Wang JD: Quality of life and climacteric complaints amongst women seeking medical advice in Taiwan: Assessment using the WHOQOL-BREF questionnaire. Climacteric. 9:119–128. 2006. View Article : Google Scholar : PubMed/NCBI
9	Dennerstein L, Dudley EC, Hopper JL, Guthrie JR and Burger HG: A prospective population-based study of menopausal symptoms. Obstet Gynecol. 96:351–358. 2000. View Article : Google Scholar : PubMed/NCBI
10	Kawada T, Yosiaki S, Yasuo K and Suzuki S: Population study on the prevalence of insomnia and insomnia-related factors among Japanese women. Sleep Med. 4:563–567. 2003. View Article : Google Scholar : PubMed/NCBI
11	Pan HA, Wu MH, Hsu CC, Yao BL and Huang KE: The perception of menopause among women in Taiwan. Maturitas. 41:269–274. 2002. View Article : Google Scholar : PubMed/NCBI
12	Shade MY, Berger AM, Dizona PJ, Pozehl BJ and Pullen CH: Sleep and health-related factors in overweight and obese rural women in a randomized controlled trial. J Behav Med. 39:386–397. 2016. View Article : Google Scholar : PubMed/NCBI
13	Chen JH, Waite LJ and Lauderdale DS: Marriage, Relationship Quality, and Sleep among U.S. Older Adults. J Health Soc Behav. 56:356–377. 2015. View Article : Google Scholar : PubMed/NCBI
14	Lampio L, Saaresranta T, Engblom J, Polo O and Polo-Kantola P: Predictors of sleep disturbance in menopausal transition. Maturitas. 94:137–142. 2016. View Article : Google Scholar : PubMed/NCBI
15	Luyster FS, Strollo PJ Jr, Zee PC and Walsh JK; Boards of Directors of the American Academy of Sleep Medicine and the Sleep Research Society, : Sleep: A health imperative. Sleep (Basel). 35:727–734. 2012. View Article : Google Scholar
16	Lobo RA: Where are we 10 years after the Women's Health Initiative? J Clin Endocrinol Metab. 98:1771–1780. 2013. View Article : Google Scholar : PubMed/NCBI
17	Formoso G, Perrone E, Maltoni S, Balduzzi S, D'Amico R, Bassi C, Basevi V, Marata AM, Magrini N and Maestri E: Short and long term effects of tibolone in postmenopausal women. Cochrane Database Syst Rev. 2012:CD0085362012.
18	Bruyneel M: Sleep disturbances in menopausal women: Aetiology and practical aspects. Maturitas. 81:406–409. 2015. View Article : Google Scholar : PubMed/NCBI
19	Cintron D, Lipford M, Larrea-Mantilla L, Spencer-Bonilla G, Lloyd R, Gionfriddo MR, Gunjal S, Farrell AM, Miller VM and Murad MH: Efficacy of menopausal hormone therapy on sleep quality: Systematic review and meta-analysis. Endocrine. 55:702–711. 2017. View Article : Google Scholar : PubMed/NCBI
20	Backhaus J, Junghanns K, Broocks A, Riemann D and Hohagen F: Test-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. J Psychosom Res. 53:737–740. 2002. View Article : Google Scholar : PubMed/NCBI
21	Mollayeva T, Thurairajah P, Burton K, Mollayeva S, Shapiro CM and Colantonio A: The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: A systematic review and meta-analysis. Sleep Med Rev. 25:52–73. 2016. View Article : Google Scholar : PubMed/NCBI
22	Devine EB, Hakim Z and Green J: A systematic review of patient-reported outcome instruments measuring sleep dysfunction in adults. Pharmacoeconomics. 23:889–912. 2005. View Article : Google Scholar : PubMed/NCBI
23	Buysse DJ, Reynolds CF III, Monk TH, Berman SR and Kupfer DJ: The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res. 28:193–213. 1989. View Article : Google Scholar : PubMed/NCBI
24	Schwartz MD and Mong JA: Estradiol modulates recovery of REM sleep in a time-of-day-dependent manner. Am J Physiol Regul Integr Comp Physiol. 305:R271–R280. 2013. View Article : Google Scholar : PubMed/NCBI
25	Mong JA, Devidze N, Goodwillie A and Pfaff DW: Reduction of lipocalin-type prostaglandin D synthase in the preoptic area of female mice mimics estradiol effects on arousal and sex behavior. Proc Natl Acad Sci USA. 100:15206–15211. 2003. View Article : Google Scholar : PubMed/NCBI
26	Polo-Kantola P, Erkkola R, Helenius H, Irjala K and Polo O: When does estrogen replacement therapy improve sleep quality? Am J Obstet Gynecol. 178:1002–1009. 1998. View Article : Google Scholar : PubMed/NCBI
27	Ohayon MM: Severe hot flashes are associated with chronic insomnia. Arch Intern Med. 166:1262–1268. 2006. View Article : Google Scholar : PubMed/NCBI
28	Shahar E, Redline S, Young T, Boland LL, Baldwin CM, Nieto FJ, O'Connor GT, Rapoport DM and Robbins JA: Hormone replacement therapy and sleep-disordered breathing. Am J Respir Crit Care Med. 167:1186–1192. 2003. View Article : Google Scholar : PubMed/NCBI
29	Krystal AD, Edinger J, Wohlgemuth W and Marsh GR: Sleep in peri-menopausal and post-menopausal women. Sleep Med Rev. 2:243–253. 1998. View Article : Google Scholar : PubMed/NCBI
30	Manber R and Armitage R: Sex, steroids, and sleep: A review. Sleep. 22:540–555. 1999.PubMed/NCBI
31	Schiff I, Regestein Q, Tulchinsky D and Ryan KJ: Effects of estrogens on sleep and psychological state of hypogonadal women. JAMA. 242:2405–4. 1979. View Article : Google Scholar : PubMed/NCBI
32	Landis CA and Moe KE: Sleep and menopause. Nurs Clin North Am. 39:97–115. 2004. View Article : Google Scholar : PubMed/NCBI
33	Genazzani AR, Facchinetti F, Ricci-Danero MG, Parrini D, Petraglia F, La Rosa R and D'Antona N: Beta-lipotropin and beta-endorphin in physiological and surgical menopause. J Endocrinol Invest. 4:375–378. 1981. View Article : Google Scholar : PubMed/NCBI
34	Taskin O, Gökdeniz R, Yalcinoglu A, Buhur A, Burak F, Atmaca R and Ozekici U: Placebo-controlled cross-over study of effects of tibolone on premenstrual symptoms and peripheral beta-endorphin concentrations in premenstrual syndrome. Hum Reprod. 13:2402–2405. 1998. View Article : Google Scholar : PubMed/NCBI